COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER

COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER

The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticue...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIN, Chia-Yang, Li Fen LEE, Denis HEALY, Shihao CHEN, Margaret MARSHALL, Shobha POTLURI, Naoki SAWADA
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticuerpo que se une específicamente a CCR4 humano y un agonista selectivo de 4-1BB, y el uso de las terapias de combinación para el tratamiento de cáncer.